Growth Metrics

Merck (MRK) Long-Term Deferred Tax (2016 - 2023)

Historic Long-Term Deferred Tax for Merck (MRK) over the last 14 years, with Q2 2023 value amounting to $10.2 billion.

  • Merck's Long-Term Deferred Tax fell 715.46% to $10.2 billion in Q2 2023 from the same period last year, while for Jun 2023 it was $10.2 billion, marking a year-over-year decrease of 715.46%. This contributed to the annual value of $9.5 billion for FY2022, which is 1773.44% down from last year.
  • Per Merck's latest filing, its Long-Term Deferred Tax stood at $10.2 billion for Q2 2023, which was down 715.46% from $10.3 billion recorded in Q1 2023.
  • In the past 5 years, Merck's Long-Term Deferred Tax ranged from a high of $11.6 billion in Q4 2021 and a low of $6.8 billion during Q4 2019
  • Its 5-year average for Long-Term Deferred Tax is $9.6 billion, with a median of $9.7 billion in 2020.
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first crashed by 1900.77% in 2020, then soared by 4869.54% in 2021.
  • Over the past 5 years, Merck's Long-Term Deferred Tax (Quarter) stood at $6.8 billion in 2019, then skyrocketed by 45.93% to $9.9 billion in 2020, then increased by 17.21% to $11.6 billion in 2021, then decreased by 17.73% to $9.5 billion in 2022, then rose by 6.92% to $10.2 billion in 2023.
  • Its Long-Term Deferred Tax stands at $10.2 billion for Q2 2023, versus $10.3 billion for Q1 2023 and $9.5 billion for Q4 2022.